Fosnetupitant and Palonosetron is given as an intravenous (IV) injection into a vein by a healthcare provider in a hospital or clinic. It is typically administered as a single dose about 30 minutes before your chemotherapy treatment begins on Day 1 of each cycle. The injection is usually given slowly over 30 minutes. It comes ready-to-use in a vial, meaning it does not need to be mixed or diluted first. You may also receive other medications, like dexamethasone, along with Fosnetupitant and Palonosetron to further help prevent nausea and vomiting. It’s crucial to follow all instructions from your healthcare team.

Fosnetupitant and Palonosetron works by blocking two different chemical signals in the body that can cause nausea and vomiting.

• Palonosetron is a 5-HT3 receptor antagonist. It blocks serotonin, a chemical released in the gut and brain during chemotherapy that triggers the vomiting reflex. Palonosetron is very effective at preventing nausea and vomiting that occurs right after chemotherapy (acute phase).
• Fosnetupitant is a prodrug of netupitant, which is a neurokinin-1 (NK-1) receptor antagonist. It blocks another chemical called Substance P, which is also involved in causing nausea and vomiting, especially in the days following chemotherapy (delayed phase).

By combining these two drugs, Fosnetupitant and Palonosetron offers comprehensive protection against both acute and delayed chemotherapy-induced nausea and vomiting.

Like all medications, Fosnetupitant and Palonosetron can cause side effects. Most are mild and often go away on their own. Common side effects include:

• Headache: This is frequently reported.
• Constipation: Changes in bowel movements, specifically constipation, can occur.
• Fatigue or feeling weak: Feeling more tired than usual is also possible.
• Upset stomach: General stomach discomfort or indigestion.
• Skin redness: Some may notice redness of the skin.

More serious but less common side effects can include severe allergic reactions (e.g., hives, swelling of the face, lips, tongue, or throat, trouble breathing) and serotonin syndrome (symptoms like agitation, confusion, fast heartbeat, muscle stiffness, sweating, or seizures). If you experience any severe or concerning side effects, especially swelling or difficulty breathing, seek immediate medical attention.

Before receiving Fosnetupitant and Palonosetron, it’s essential to discuss your full medical history with your doctor, especially if you have:

• Allergies: Tell your doctor if you have ever had an allergic reaction to fosnetupitant, palonosetron, or similar anti-nausea medications (like ondansetron or granisetron).
• Kidney disease: Severe kidney problems might prevent safe use of this medication.
• Liver disease: Severe liver problems may also affect how this medication is processed in your body, requiring careful consideration.
• Serotonin syndrome risk: If you are taking other medications that affect serotonin levels (e.g., certain antidepressants, triptans for migraines, opioids, St. John’s Wort), there’s an increased risk of serotonin syndrome. Your doctor will monitor you closely for symptoms.
• Pregnancy and breastfeeding: This medication may harm an unborn baby and is generally not recommended during pregnancy. It is also advised to discuss breastfeeding with your doctor, as it’s unclear if the drug passes into breast milk.

It is very important to tell your doctor about all other medicines you are taking, including over-the-counter drugs, vitamins, and herbal supplements, as Fosnetupitant and Palonosetron can interact with them.

• Dexamethasone: This steroid is often given with Fosnetupitant and Palonosetron. The dose of dexamethasone usually needs to be reduced when given with this medication because Fosnetupitant can increase its levels in the body.
• CYP3A4 metabolized drugs: Fosnetupitant can affect how certain other medicines are broken down by the body (those metabolized by CYP3A4 enzymes). This can increase the levels of these other medicines, potentially leading to more side effects. Examples include some cancer medications, benzodiazepines (like midazolam), and antifungals (like ketoconazole).
• Serotonergic drugs: Taking this medicine with other drugs that increase serotonin levels (e.g., certain antidepressants, opioid pain relievers) can lead to a serious condition called serotonin syndrome.
• Strong CYP3A4 inducers (e.g., rifampin): These can make Fosnetupitant less effective.

Always provide a complete medication list to your healthcare provider to prevent dangerous interactions.

Fosnetupitant and Palonosetron is given as a single intravenous (IV) infusion for each chemotherapy cycle.

• Adults: The typical dose is 235 mg of fosnetupitant combined with 0.25 mg of palonosetron.
• Administration: It is infused slowly over 30 minutes, starting approximately 30 minutes before your chemotherapy on Day 1.
• Combination therapy: This medication is used in combination with other antiemetics, most commonly dexamethasone. Your doctor will also adjust your dexamethasone dose when you receive Fosnetupitant and Palonosetron.
• Renal/Liver impairment: For patients with mild to moderate kidney or liver problems, no dose adjustment is usually needed. However, it is generally not recommended for patients with severe kidney or liver disease.

Always ensure a healthcare professional administers this medication and adheres to the prescribed dosage.

Fosnetupitant and Palonosetron is a prescription-only medication, meaning you cannot obtain it without a doctor’s order. The prescription process involves:

• Diagnosis: It is prescribed specifically for the prevention of chemotherapy-induced nausea and vomiting, particularly with highly emetogenic chemotherapy. Your oncologist (cancer doctor) will determine if it’s appropriate for your chemotherapy regimen.
• Medical evaluation: A thorough review of your medical history, including any kidney or liver conditions, allergies, and all other medications you are taking, is essential to ensure safety and prevent drug interactions.
• Specialist administration: As an injectable medication administered intravenously, it requires administration by trained healthcare professionals in a clinical setting. This ensures proper dosing and monitoring for immediate reactions.
• Ongoing monitoring: Your healthcare team will monitor you for effectiveness and any side effects throughout your chemotherapy cycles.

Due to the nature of its use and potential interactions, it is crucial that this medication is prescribed and overseen by a qualified healthcare professional experienced in cancer care

1. What is this injection used for? Prevention of acute and delayed nausea and vomiting due to chemotherapy

2. What are the active ingredients? Fosnetupitant (prodrug of netupitant) and palonosetron

3. What drug class does it belong to? Miscellaneous antiemetics

4. Is it a controlled substance? No

5. Is it available in generic form? No

6. How is it administered? Intravenous injection, typically 30 minutes before chemotherapy

7. What strengths are available? 235 mg fosnetupitant + 0.25 mg palonosetron per 20 mL solution

8. What is the usual dosage? Single IV dose before chemotherapy; used with dexamethasone

9. Can it be used in children? Not approved for pediatric use

10. What are common side effects? Headache, fatigue, constipation, infusion site reactions

11. Can it cause serious reactions? Yes—hypersensitivity, serotonin syndrome, QT prolongation

12. Is it safe during pregnancy? Use only if clearly needed; consult a healthcare provider

13. Is a prescription required? Yes

14. Is it available in Pakistan? May be available via oncology centers or import

15. What precautions should be taken during use? Monitor for allergic reactions and cardiac rhythm changes

16. Can it be used with other antiemetics? Yes—often combined with dexamethasone

17. What are contraindications? Hypersensitivity to either component

18. What monitoring is needed during use? ECG (QT interval), liver function, infusion site

19. What is the mechanism of action? Blocks NK1 and 5-HT3 receptors to prevent emesis

20. What are similar products? Aprepitant + ondansetron, granisetron, palonosetron alone